Singapore-based synthetic biology startup Allozymes has raised $5 million in seed funding led by Xora Innovation, the deep science investment arm of Temasek Holdings. The round was also joined by SOSV, TI Platform Management and Entrepreneur First.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
